针对侵袭性真菌病患者进行分类:走向统一病例定义?
Mehmet Ergün1,2, Roger J M Brüggemann1,3, Alexandre Alanio4,5
1Radboudumc-CWZ Center of Expertise for Mycology, Radboud University Medical Center, Nijmegen, The Netherlands.
The Journal of antimicrobial chemotherapy
|July 24, 2025
概括
开发一种机器学习 (ML) 模型可以改善侵入性真菌病 (IFD) 的分类. 这种方法旨在通过从数据中学习来标准化诊断,解决目前IFD病例定义中的局限性.
科学领域:
- 菌类学 菌类学是指菌类学.
- 传染性疾病 传染性疾病
- 计算生物学 计算生物学
背景情况:
- 侵袭性真菌病 (IFD) 由于新风险群体,新出现的病原体和抗真菌耐药性而带来越来越多的管理挑战.
- 目前的IFD病例定义在研究和临床分类方面变得越来越无效.
- 现有的定义通常依赖于单一的阳性测试,不考虑矛盾的证据.
研究的目的:
- 探索基于机器学习 (ML) 的IFD分类模型的开发.
- 创建一种标准化且不那么模糊的方法来诊断IFD,特别是未被证明的病例.
主要方法:
- 建议使用机器学习算法从观察到的数据中自动学习.
- 开发一个分类模型,可以一致和准确地分类IFD.
主要成果:
- 该研究提出了一种基于ML的新方法,用于IFD分类.
- 这种方法旨在克服当前案例定义的局限性.
结论:
- 开发和验证基于ML的IFD分类模型是一个重要的,但值得的努力.
- 这种模型可以标准化IFD诊断,并减少真菌学界的模两可.
相关概念视频
Fungal Group Zygomycota
122
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
122
Fungal Phylum Basidiomycota
226
Basidiomycota is a diverse phylum of fungi that includes ecologically significant decomposers such as white rot fungi, symbionts like mycorrhizal fungi, plant pathogens such as rusts and smuts, and edible species like Agaricus bisporus (the common button mushroom). These fungi play crucial roles in nutrient cycling, symbiotic relationships, and even human health. Their defining feature is the basidium, a microscopic club-shaped structure responsible for producing basidiospores.Fruiting Bodies...
226
Fungal Phylum Microsporidia
122
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
122
Urinary Tract Infection I: Introduction
51
Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
51
Fungal Phylum Ascomycota
155
Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
155
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
4.4K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.4K


